PXMP2

gene
On this page

Also known as PMP22MPV17L3

Summary

PXMP2 (peroxisomal membrane protein 2, HGNC:9716) is a protein-coding gene on chromosome 12q24.33, encoding Peroxisomal membrane protein 2 (Q9NR77). Seems to be involved in pore-forming activity and may contribute to the unspecific permeability of the peroxisomal membrane.

Located in peroxisomal membrane. Part of protein-containing complex.

Source: NCBI Gene 5827 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 40 total — 1 pathogenic
  • MANE Select transcript: NM_018663

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9716
Approved symbolPXMP2
Nameperoxisomal membrane protein 2
Location12q24.33
Locus typegene with protein product
StatusApproved
AliasesPMP22, MPV17L3
Ensembl geneENSG00000176894
Ensembl biotypeprotein_coding
OMIM617399
Entrez5827

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 8 protein_coding, 1 nonsense_mediated_decay

ENST00000317479, ENST00000428960, ENST00000454379, ENST00000539093, ENST00000543589, ENST00000856532, ENST00000856533, ENST00000856534, ENST00000856535

RefSeq mRNA: 1 — MANE Select: NM_018663 NM_018663

CCDS: CCDS9279

Canonical transcript exons

ENST00000317479 — 5 exons

ExonStartEnd
ENSE00001293459132687587132687792
ENSE00002230284132704619132704985
ENSE00003467180132701250132701369
ENSE00003468031132690263132690376
ENSE00003715973132695884132696046

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 98.68.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.0443 / max 167.0632, expressed in 1767 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
12882818.04431767

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111498.68gold quality
liverUBERON:000210798.16gold quality
mucosa of transverse colonUBERON:000499197.90gold quality
body of stomachUBERON:000116195.69gold quality
apex of heartUBERON:000209895.09gold quality
duodenumUBERON:000211495.09gold quality
adult mammalian kidneyUBERON:000008294.96gold quality
fundus of stomachUBERON:000116094.62gold quality
heart left ventricleUBERON:000208494.49gold quality
stomachUBERON:000094594.45gold quality
ventricular zoneUBERON:000305393.63gold quality
transverse colonUBERON:000115793.60gold quality
ganglionic eminenceUBERON:000402392.56gold quality
kidneyUBERON:000211392.54gold quality
heartUBERON:000094892.52gold quality
gastrocnemiusUBERON:000138891.87gold quality
small intestine Peyer’s patchUBERON:000345491.75gold quality
rectumUBERON:000105291.72gold quality
body of pancreasUBERON:000115091.69gold quality
small intestineUBERON:000210891.57gold quality
muscle of legUBERON:000138391.51gold quality
right atrium auricular regionUBERON:000663191.27gold quality
hindlimb stylopod muscleUBERON:000425291.15gold quality
skeletal muscle tissueUBERON:000113490.47gold quality
thoracic aortaUBERON:000151590.41gold quality
descending thoracic aortaUBERON:000234590.37gold quality
ascending aortaUBERON:000149690.33gold quality
intestineUBERON:000016090.17gold quality
colonUBERON:000115589.80gold quality
cortex of kidneyUBERON:000122589.73gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.69

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

10 targeting PXMP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-153-5P99.8973.866317
HSA-MIR-4756-3P99.6266.301319
HSA-MIR-20A-3P99.4469.101575
HSA-MIR-7151-5P99.3767.82613
HSA-MIR-6719-3P99.2967.781387
HSA-MIR-6804-3P98.7264.82852
HSA-MIR-3622A-3P97.0666.431000
HSA-MIR-4793-5P96.8865.90872
HSA-MIR-3622B-3P96.8266.36988
HSA-MIR-152-5P96.4266.59960

Literature-anchored findings (GeneRIF, showing 1)

  • Authors provide evidence that PXMP2 is not essential for H2O2 permeation across the peroxisomal membrane, neither in control cells nor in cells lacking PEX11B, a peroxisomal membrane-shaping protein whose yeast homologue facilitates the permeation of molecules up to 400Da. (PMID:31129117)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriopxmp2ENSDARG00000003144
mus_musculusPxmp2ENSMUSG00000029499
rattus_norvegicusPxmp2ENSRNOG00000037446
drosophila_melanogasterCG7970FBGN0035252

Paralogs (3): MPV17 (ENSG00000115204), MPV17L (ENSG00000156968), MPV17L2 (ENSG00000254858)

Protein

Protein identifiers

Peroxisomal membrane protein 2Q9NR77 (reviewed: Q9NR77)

Alternative names: 22 kDa peroxisomal membrane protein

All UniProt accessions (5): A0A087X249, Q9NR77, F5GXM0, F5GZF7, F5H4N4

UniProt curated annotations — full annotation on UniProt →

Function. Seems to be involved in pore-forming activity and may contribute to the unspecific permeability of the peroxisomal membrane.

Subunit / interactions. Interacts with PEX19 and SIVA1.

Subcellular location. Peroxisome membrane.

Similarity. Belongs to the peroxisomal membrane protein PXMP2/4 family.

RefSeq proteins (1): NP_061133* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007248Mpv17_PMP22Family

Pfam: PF04117

UniProt features (9 total): topological domain 4, transmembrane region 4, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NR77-F185.580.51

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-389661Glyoxylate metabolism and glycine degradation
R-HSA-9603798Class I peroxisomal membrane protein import

MSigDB gene sets: 757 (showing top): WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN, TGGTGCT_MIR29A_MIR29B_MIR29C, chr17p12, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, BENPORATH_ES_WITH_H3K27ME3, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN, YAGI_AML_WITH_INV_16_TRANSLOCATION, KAAB_FAILED_HEART_ATRIUM_DN, GNF2_GSTM1, GNF2_HPN, ASTON_MAJOR_DEPRESSIVE_DISORDER_DN, SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER, GOBP_NEUROGENESIS, KANNAN_TP53_TARGETS_DN, TOMLINS_PROSTATE_CANCER_DN

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (6): cytoplasm (GO:0005737), peroxisomal membrane (GO:0005778), cytosol (GO:0005829), membrane (GO:0016020), protein-containing complex (GO:0032991), peroxisome (GO:0005777)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Metabolism of amino acids and derivatives1
Protein localization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
binding1
intracellular anatomical structure1
peroxisome1
microbody membrane1
cytoplasm1
cellular_component1
microbody1

Protein interactions and networks

STRING

1072 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PXMP2PEX11AO75192653
PXMP2PEX11BO96011651
PXMP2PEX16Q9Y5Y5597
PXMP2PXMP4Q9Y6I8571
PXMP2PEX11GQ96HA9549
PXMP2DAOP14920532
PXMP2ACBD5Q5T8D3501
PXMP2SLC25A17O43808489
PXMP2ALDH3A2P51648470
PXMP2PEX13Q92968468
PXMP2SNX15Q9NRS6466
PXMP2NUDT12Q9BQG2459
PXMP2ABCD1P33897458
PXMP2H3BMD7H3BMD7453
PXMP2HAO1Q9UJM8448

IntAct

73 interactions, top by confidence:

ABTypeScore
IFT70BIFT56psi-mi:“MI:0914”(association)0.790
PXMP2PEX19psi-mi:“MI:0915”(physical association)0.770
PXMP2PEX19psi-mi:“MI:0407”(direct interaction)0.770
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
MMETMEM223psi-mi:“MI:0914”(association)0.530
SLC15A1METTL15psi-mi:“MI:0914”(association)0.530
SLC39A9B4GALT5psi-mi:“MI:0914”(association)0.530
PEX19FAM20Bpsi-mi:“MI:0914”(association)0.530
SLC22A16APBA3psi-mi:“MI:0914”(association)0.530
PEX19MYO1Dpsi-mi:“MI:0914”(association)0.530
PXMP2SIVA1psi-mi:“MI:0915”(physical association)0.510
SIVA1PXMP2psi-mi:“MI:0915”(physical association)0.510
GPC1SNAP23psi-mi:“MI:0915”(physical association)0.400
GPC1GANABpsi-mi:“MI:0915”(physical association)0.400
ERGIC3TMEM223psi-mi:“MI:0914”(association)0.350
TMCO3POTEFpsi-mi:“MI:0914”(association)0.350
SLC18A1LIMK2psi-mi:“MI:0914”(association)0.350
FPR2GPR89Apsi-mi:“MI:0914”(association)0.350
SLC5A8GPR89Apsi-mi:“MI:0914”(association)0.350
SLC6A15GPR89Apsi-mi:“MI:0914”(association)0.350
SLC1A1TNFRSF10Bpsi-mi:“MI:0914”(association)0.350
SLC22A16AGPAT2psi-mi:“MI:0914”(association)0.350

BioGRID (301): KRT40 (Two-hybrid), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS), PXMP2 (Affinity Capture-MS)

ESM2 similar proteins: A6ZV78, A7A285, A8E7G5, B0G159, B3LUQ6, B5VI70, O14142, P0CQ38, P0CQ39, P38857, P40464, P42925, P43617, P53257, Q06563, Q07066, Q10244, Q2KIK2, Q2KIY1, Q2QL34, Q3ZCG2, Q4P9K6, Q4WDZ0, Q54FR4, Q54GD8, Q54XX9, Q54ZX5, Q59Q43, Q5EA43, Q5RD16, Q60SZ2, Q68F62, Q6BMY0, Q6CAW5, Q6CIY7, Q6FXJ3, Q754F0, Q7YWV6, Q86I81, Q925N2

Diamond homologs: O14142, P0CQ38, P0CQ39, P19258, P39210, P42925, Q06563, Q07066, Q08743, Q10244, Q2KIN6, Q2KIY1, Q2TXA2, Q4IPX8, Q4P9K6, Q4WDZ0, Q54XX9, Q54ZX5, Q59Q43, Q5BK62, Q5TZ51, Q60SZ2, Q66GV0, Q6BMY0, Q6CAW5, Q6CIY7, Q6FXJ3, Q754F0, Q7SCY7, Q9NR77, Q54FR4, Q54GD8, Q6DGV7, Q2QL34, Q567V2, Q8VIK2, A5D787, Q6DIY8, Q7YWV6, Q99MS3

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 82 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
R-HSA-425393615.0×2e-04
SLC-mediated transmembrane transport1011.4×3e-06
Transport of small molecules136.3×9e-06

GO biological processes:

GO termPartnersFoldFDR
sodium ion transport517.4×3e-03
monoatomic ion transport612.0×3e-03
intracellular calcium ion homeostasis611.2×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

40 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance25
Likely benign3
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
638102GRCh37/hg19 12q24.33(chr12:131363916-133777645)x3Pathogenic

SpliceAI

1558 predictions. Top by Δscore:

VariantEffectΔscore
12:132687792:GGTG:Gdonor_loss1.0000
12:132687793:GTGAG:Gdonor_loss1.0000
12:132690261:A:AGacceptor_gain1.0000
12:132690262:G:GGacceptor_gain1.0000
12:132690262:GTGGC:Gacceptor_gain1.0000
12:132690375:GG:Gdonor_gain1.0000
12:132690376:GG:Gdonor_gain1.0000
12:132690377:G:GGdonor_gain1.0000
12:132690377:G:Tdonor_loss1.0000
12:132690378:T:Adonor_loss1.0000
12:132701244:TTGCA:Tacceptor_loss1.0000
12:132701245:T:TAacceptor_gain1.0000
12:132701245:TGCAG:Tacceptor_loss1.0000
12:132701246:GCA:Gacceptor_loss1.0000
12:132701247:CA:Cacceptor_loss1.0000
12:132701247:CAG:Cacceptor_loss1.0000
12:132701248:A:ACacceptor_loss1.0000
12:132701248:A:AGacceptor_gain1.0000
12:132701248:AG:Aacceptor_gain1.0000
12:132701248:AGG:Aacceptor_gain1.0000
12:132701248:AGGG:Aacceptor_gain1.0000
12:132701249:G:GTacceptor_gain1.0000
12:132701249:GG:Gacceptor_gain1.0000
12:132701249:GGG:Gacceptor_gain1.0000
12:132701249:GGGG:Gacceptor_gain1.0000
12:132701366:GAAG:Gdonor_gain1.0000
12:132701368:AGG:Adonor_loss1.0000
12:132701369:GGTG:Gdonor_loss1.0000
12:132701370:G:GAdonor_loss1.0000
12:132701370:GTGAG:Gdonor_loss1.0000

AlphaMissense

1258 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:132701348:C:AN166K0.986
12:132701348:C:GN166K0.986
12:132690265:G:AG42D0.985
12:132690376:G:AG79E0.985
12:132701359:T:AV170D0.985
12:132690264:G:CG42R0.979
12:132687791:A:CS41R0.978
12:132690263:T:AS41R0.978
12:132690263:T:GS41R0.978
12:132695897:G:TG84W0.978
12:132701344:T:AI165N0.978
12:132695906:A:CS87R0.977
12:132695908:T:AS87R0.977
12:132695908:T:GS87R0.977
12:132701315:C:AN155K0.977
12:132701315:C:GN155K0.977
12:132690375:G:TG79W0.976
12:132701316:T:AW156R0.976
12:132701316:T:CW156R0.976
12:132701327:G:CW159C0.976
12:132701327:G:TW159C0.976
12:132695898:G:AG84E0.975
12:132696020:T:CF125L0.974
12:132696022:C:AF125L0.974
12:132696022:C:GF125L0.974
12:132687782:G:CA38P0.972
12:132701325:T:AW159R0.972
12:132701325:T:CW159R0.972
12:132690367:C:AA76D0.970
12:132704639:C:AN180K0.969

dbSNP variants (sampled 300 via entrez): RS1000230189 (12:132705482 G>A), RS1000334479 (12:132699879 G>A,T), RS1000541182 (12:132691866 A>G), RS1000593110 (12:132685961 C>T), RS10007 (12:132704876 G>A), RS1000795616 (12:132705447 C>T), RS1000958627 (12:132702206 A>G), RS1001129293 (12:132699687 G>A), RS1001136456 (12:132696339 C>T), RS1001286705 (12:132704955 A>T), RS1001361950 (12:132691207 A>G), RS1001410417 (12:132699815 A>G), RS1001430551 (12:132685651 A>G), RS1001430822 (12:132687642 G>A,C,T), RS1001476439 (12:132687494 A>G)

Disease associations

OMIM: gene MIM:617399 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST90002387_131Immature fraction of reticulocytes5.000000e-12
GCST90002390_181Mean corpuscular hemoglobin7.000000e-13
GCST90002396_544Mean reticulocyte volume2.000000e-10
GCST90002397_53Mean spheric corpuscular volume3.000000e-11

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004527mean corpuscular hemoglobin
EFO:0010701mean reticulocyte volume

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

41 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1affects expression, decreases expression4
sodium arseniteincreases expression, decreases expression, affects cotreatment, increases abundance3
Cyclosporinedecreases expression3
Benzo(a)pyrenedecreases expression2
Nickeldecreases expression2
Ozoneaffects expression, increases abundance, increases expression2
sotorasibaffects cotreatment, increases expression1
methylmercuric chloridedecreases expression1
pirinixic acidincreases activity, affects binding, decreases expression1
bisphenol Aaffects expression1
beta-lapachonedecreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
cobaltous chloridedecreases expression1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
periodate-oxidized adenosineaffects expression1
perfluoro-n-nonanoic aciddecreases expression1
K 7174decreases expression1
erucylphospho-N,N,N-trimethylpropylammoniumdecreases expression1
trametinibaffects cotreatment, increases expression1
(+)-JQ1 compounddecreases expression1
MT19c compounddecreases expression1
NVP-BKM120affects cotreatment, increases expression1
Temozolomideincreases expression1
Arsenic Trioxideincreases expression1
Acetaminophendecreases expression1
Air Pollutantsincreases abundance, affects expression1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Cisplatinincreases expression1
Hydrogen Peroxideaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.